Symbol="VXRT"
AssetType="Common Stock"
Name="Vaxart Inc"
Description="Vaxart, Inc., a clinical-stage biotechnology company, is dedicated to the discovery and development of oral recombinant protein vaccines based on its proprietary oral vaccine platform. The company is headquartered in South San Francisco, California."
CIK="72444"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)"
Address="2500 NORTHWINDS PARKWAY, SUITE 100, ALPHARETTA, GE"
FiscalYearEnd="December"
LatestQuarter="2023-06-30"
MarketCapitalization="109150000"
EBITDA="-97254000"
PERatio="None"
PEGRatio="None"
BookValue="0.56"
DividendPerShare="0"
DividendYield="0"
EPS="-0.84"
RevenuePerShareTTM="0.015"
ProfitMargin="0"
OperatingMarginTTM="-51.06"
ReturnOnAssetsTTM="-0.431"
ReturnOnEquityTTM="-0.885"
RevenueTTM="2055000"
GrossProfitTTM="-80947000"
DilutedEPSTTM="-0.84"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="6.94"
AnalystTargetPrice="6.13"
TrailingPE="-"
ForwardPE="42.73"
PriceToSalesRatioTTM="916.27"
PriceToBookRatio="1.105"
EVToRevenue="267.85"
EVToEBITDA="-0.434"
Beta="0.625"
num_52WeekHigh="4.615"
num_52WeekLow="0.56"
num_50DayMovingAverage="0.873"
num_200DayMovingAverage="1.003"
SharesOutstanding="151597000"
DividendDate="2018-02-14"
ExDividendDate="2012-11-09"
symbol="VXRT"
open="0.72"
high="0.73"
low="0.71"
price="0.73"
volume="625133.00"
latest_trading_day="2023-08-08"
previous_close="0.72"
change="0.01"
change_percent="0.9167%"
aroon_positive_momentum_days="0"
aroon_negative_momentum_days="53"
trend_strength="Absent or Weak Trend"
buying_signal="Weak Sell Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="FALSE"
Aroon_momentum="47"
Volume_recent_avg="1883101"
Change_recent_avg="0.01"
Delta_recent_avg="0.07"
Variance_recent_avg="0.04"
Change_ratio_recent_avg="-0.2"
RSI_change="FALSE"
ADX_change="FALSE"

event="FALSE"
Aroon_signal="negative"
Aroon_change="FALSE"
Aroon_momentum_positive="47"
Aroon_momentum_negative="53"
image_negative_thumbnail_id_1="513"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0092.jpeg"
image_negative_thumbnail_id_2="502"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0103.jpeg"
image_neutral_thumbnail_id_1="552"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0047.jpeg"
image_neutral_thumbnail_id_2="582"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0017.jpeg"
image_positive_thumbnail_id_1="1003"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0165.jpeg"
image_positive_thumbnail_id_2="1005"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0167.jpeg"
image_professor_thumbnail_id_1="1174"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0008.jpeg"
image_professor_thumbnail_id_2="1194"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0028.jpeg"
